Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2793121000168113 | Synagis (palivizumab 100 mg / 1 mL) injection, 1 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2793131000168111 | Synagis 100 mg/mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Synagis 100 mg/mL injection, vial | Is a | palivizumab 100 mg/mL injection, vial | true | Inferred relationship | Some | ||
| Synagis 100 mg/mL injection, vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Synagis 100 mg/mL injection, vial | Is a | Synagis | true | Inferred relationship | Some | ||
| Synagis 100 mg/mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Synagis 100 mg/mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1606495423 | |
| Synagis 100 mg/mL injection, vial | has intended active ingredient | palivizumab | true | Inferred relationship | Some | 1606495422 | |
| Synagis 100 mg/mL injection, vial | has Australian BoSS | palivizumab | true | Inferred relationship | Some | 1606495422 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Synagis 100 mg/mL injection, 1 mL vial | has TPUU | True | Synagis 100 mg/mL injection, vial | Inferred relationship | Some | 1 |
| Synagis 100 mg/mL injection, 1 mL vial | has TPUU | True | Synagis 100 mg/mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR